Priced at a premium to peer multiples and intrinsic cash flows, demanding strong execution to justify current levels.
High-quality fundamentals with a strong composite quality score of 77/100, backed by robust profitability and solvency.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Solid fundamental quality, though profitability presents a headwind.
Wall Street is cautious, forecasting potential downside alongside robust expected earnings growth. However, capital return yields remain modest, driven predominantly by aggressive share repurchases.
Returns capital exclusively via buybacks — no active dividend
MRVL demonstrates adequate business quality with stable profitability. This is supported by a highly conservative balance sheet featuring strong liquidity and pristine Altman Z safety.
The company demonstrates solid revenue growth (11.4% 3Y CAGR) paired with stable bottom-line earnings. The company maintains healthy operational efficiency with a 16.2% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | +42.1% | +11.4% | +22.5% | +12.0% | |
| EBITDA | $670.7M | — | +17.3% | — | — | |
| Net Income | $34.5M | +401.7% | — | — | — | |
| EPS (Diluted) | $0.04 | +401.0% | — | — | — | |
| Free Cash Flow | $483.1M | +0.5% | +9.2% | +14.9% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 50.6% | 44.7% | 46.1% | 49.9% |
| Operating Margin | 16.2% | -2.2% | -2.0% | 1.1% |
| Net Margin | 29.0% | 0.1% | -2.4% | 5.0% |
| FCF Margin | 19.1% | 19.9% | 18.4% | 14.7% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.80 | $0.80 | +0.3% | ||
| Q1'26 | $0.79 | $0.80 | +1.0% | ||
| Q4'25 | $0.74 | $0.76 | +2.3% | ||
| Q3'25 | $0.67 | $0.67 | -0.4% | ||
| Q2'25 | $0.61 | $0.62 | +1.3% | ||
| Q1'25 | $0.59 | $0.60 | +1.7% | ||
| Q4'24 | $0.41 | $0.43 | +4.9% | ||
| Q3'24 | $0.29 | $0.30 | +2.2% |
Total return is +314.7% (1Y), outperforming the benchmark by +289.7%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +247.6% | +238.3% | — |
| 1Y | +314.7% | +289.7% | +0.3% |
| 3YCAGR | +72.3% | +48.8% | +1.2% |
| 5YCAGR | +41.9% | +27.0% | +2.2% |
| 10YCAGR | +40.9% | +26.5% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Marvell Technology, Inc. (MRVL) valuation, health, and returns.
Marvell Technology, Inc. is estimated to be overvalued under our discounted cash flow framework. relative multiples indicate the stock is Expensive versus peers compared to industry peers. overvalued (implying -64.5% downside from DCF intrinsic value of $110.18)
Marvell Technology, Inc. has multiple valuation anchors: DCF Intrinsic Value: $110.18 | Peer Relative Fair Value: $145.45 | Wall Street Analyst Target: $241.46 (implying -22.3% upside). A convergence of these signals offers higher conviction.
Marvell Technology, Inc. displays good financial health with a composite quality score of 77/100, supported by a Altman Z-Score of 21.0 (safe zone), Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 6.0%.
Marvell Technology, Inc. returns capital via buybacks instead of dividends, carrying a 0.8% buyback yield and reducing outstanding shares by +0.5% in the last 12 months.
Marvell Technology, Inc.'s current growth trajectory is Accelerating. The company achieved +42.1% 1Y revenue growth and +401.0% 1Y EPS growth, compared to its 3Y revenue CAGR of +11.4%.
Wall Street consensus is Buy based on 73 analysts, beating EPS expectations in 83% of recent quarters with a 3-quarter streak. The consensus price target represents a -22.3% change from current levels.
Investment risks for Marvell Technology, Inc. include: -25.5% 1-year max drawdown, high beta (2.72x market volatility). Volatility risk is characterized by a beta of 2.72x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.